Category: Gene Therapy
Global Gene Therapy
-
Global Gene Therapy Drug Delivery Tube Market Growth 2023-2029
... demand in downstream market, the Gene Therapy Drug Delivery Tube is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Gene Therapy Drug Delivery Tube Supply, Demand and Key Producers, 2023-2029
... % CAGR during the forecast period (2023-2029). This report studies the global Gene Therapy Drug Delivery Tube production, demand, key manufacturers, and key regions. This report is a detailed and comprehensive analysis of the world ... Read More
-
Global Gene Therapy Drug Delivery Tube Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The Global Info Research report includes an overview of ... Read More
-
Biologics Fill / Finish Services Market (3rd Edition), 2022-2035
... of various industry and academic stakeholders. Currently, more than 200 biologics are commercially available and over 10,000 candidates are under clinical evaluation. With the increasing demand and diversity of biologics, an increase in the demand ... Read More
-
Global Cell and Gene Therapy Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... market growth of the Cell and Gene Therapy industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Cell and Gene Therapy. The report ... Read More
-
Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area (Neurology, Oncology), Delivery Method (In-vivo, Ex-vivo), RoA (Intravenous) & Region - Global Forecast to 2028
... market is expected to reach USD 23.9 billion by 2028 from USD 9.0 billion in 2023, at a CAGR of 21.4% during the forecast period. The key factors driving the growth of the gene therapy ... Read More
-
Global Cell and Gene Therapy CDMO Market Growth (Status and Outlook) 2023-2029
... 2022. With growing demand in downstream market, the Cell and Gene Therapy CDMO is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report ... Read More
-
Global Cell and Gene Therapy CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The Global Info Research report includes an overview of ... Read More
-
Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029
... % CAGR during the forecast period (2023-2029). This report studies the global Cell and Gene Therapy CDMO demand, key companies, and key regions. This report is a detailed and comprehensive analysis of the world market ... Read More
-
Global Cell and Gene Therapy Manufacturing Quality Control Market Growth (Status and Outlook) 2023-2029
... at US$ 391.3 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Cell and Gene Therapy Manufacturing Quality Control is forecast to a readjusted ... Read More
-
Biologic Therapeutics Market Forecasts to 2030 – Global Analysis By Product (Gene Therapy, Cell Therapy, Vaccines, Antibody Therapeutics and Other Products), Type, Application and By Geography
... is accounted for $457.56 billion in 2023 and is expected to reach $968.08 billion by 2030 growing at a CAGR of 11.3% during the forecast period. The pharmaceutical industry sector that concentrates on the development, ... Read More
-
Biopharmaceuticals Market Forecasts to 2030 – Global Analysis By Product Type (Monoclonal Antibodies, Interferon, Insulin, Growth and Coagulation Factor, Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Synthetic Immunomodulators, Recombinant Hormones, Recombinant Enzymes, Cell and Gene Therapies, Synthetic Immunomodulators and Other Product Types), Application and By Geography
... Gene Therapies, Synthetic Immunomodulators and Other Product Types), Application and By Geography According to Stratistics MRC, the Global Biopharmaceuticals Market is accounted for $1047.45 million in 2023 and is expected to reach $2686.05 million by ... Read More
-
Cancer Gene Therapy Market by Therapy (Gene Induced Immunotherapy, Gene Transfer, Oncolytic Virotherapy), Indication (Breast Cancer, Liver Cancer, Lung Cancer), End-Use - Global Forecast 2023-2030
... 7.99 billion by 2030 from USD 1.78 billion in 2022, at a CAGR of 20.63% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends ... Read More
-
Bladder Cancer Therapeutics Market by Treatment Type (Chemotherapy, Gene Therapy, Immunotherapy), Bladder Cancer Type (Invasive Bladder Cancer, Squamous Cell Bladder Cancer, Superficial Bladder Cancer), End-User - Global Forecast 2023-2030
... projected to reach USD 8.49 billion by 2030 from USD 4.90 billion in 2022, at a CAGR of 7.12% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Cell Line (In-vitro, In-Vivo), Type (Adeno-Associated Virus, Adenovirus, Lentivirus), Transfection, Indication, Workflow, Application, End User - Global Forecast 2023-2030
... is projected to reach USD 7.32 billion by 2030 from USD 1.20 billion in 2022, at a CAGR of 25.30% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts ... Read More
-
Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Pituitary Tumors), Therapy (Gene Therapy, Immunotherapy, Tissue Engineering) - Global Forecast 2023-2030
... USD 2.80 billion in 2022, at a CAGR of 8.22% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide ... Read More
-
Pompe Disease Global Market Report 2023 Including: 1) By Type: Classic Infantile Form; Non-Classic Infantile Form; Late-Onset Form 2) By Diagnosis: Blood Test; Genetic Test; Prenatal Test 3) By Route of Administration: Oral; Parenterals 4) By Therapy Type: Enzyme Replacement Therapy (ERT); Substrate Reduction Therapy (SRT); Gene Therapy 5) By End Users: Hospitals / Clinics; Pharmaceuticals; Researchers Covering: F. Hoffmann-La Roche AG; Bayer AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.
... Enzyme Replacement Therapy (ERT); Substrate Reduction Therapy (SRT); Gene Therapy5) By End Users: Hospitals / Clinics; Pharmaceuticals; ResearchersCovering: F. Hoffmann-La Roche AG; Bayer AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc. Pompe Disease Global ... Read More
-
Fill Finish Manufacturing Global Market Report 2023 Including: 1) By Product: Consumables; Instruments 2) By Modality: Recombinant Proteins; Monoclonal Antibodies; Vaccines; Cell Therapies; Viral Gene Therapies; Non-Viral Gene Therapies 3) By End-User: Contract Manufacturing Organizations; Biopharmaceutical Companiess Covering: Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc.
... Johnson And Johnson; AbbVie Inc.; Thermo Fisher Scientific Inc.; Becton Dickinson And Company; Baxter International Inc. Fill Finish Manufacturing Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with ... Read More
-
Cell and Gene Therapy Manufacturing Services Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopaedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... and Non-Viral Vector)], Indication (Cancer, Orthopaedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)], and Geography (North America, Europe, Asia Pacific, Middle East & ... Read More
-
Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecasts to 2028
... manufacturing market is estimated to reach USD 24.8 billion by 2028 from USD 16.6 billion in 2023, at a CAGR of 8.3% during the forecast period of 2023 to 2028. The growth of this market ... Read More
-
Cell & Gene Therapy Bioanalytical Testing Services Market - Global Cell & Gene Therapy Bioanalytical Testing Services Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Test Type Coverage, By Therapy Type Coverage, By End User Coverage, By Indication Coverage, By Geographic Coverage and Leading Companies)
... Type Coverage, By End User Coverage, By Indication Coverage, By Geographic Coverage and Leading Companies) Cell & Gene Therapy Bioanalytical Testing Services Market Set to Soar with a Projected CAGR of 8% by 2030 The ... Read More
-
Precision Medicine Market by Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), Indication (Oncology, Rare diseases, Hematology, Infectious), End user (Hospitals & Clinics, Home care) & Region - Global Forecast to 2028
... precision medicine market is expected to reach USD 50.2 billion by 2028 from USD 29.1 billion in 2023, at a CAGR of 11.5% during the forecast period. The key factors driving the growth of the ... Read More
-
Global Gene Therapy for Neurodegenerative Diseases Market Growth (Status and Outlook) 2023-2029
... 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Gene Therapy for Neurodegenerative Diseases is forecast to a readjusted size of US$ million by 2029 with ... Read More
-
Regenerative Medicine Market - By Type (Cell Therapy, Tissue Engineering, Gene Therapy), By Application (Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound Healing, Ophthalmology), Global Forecast (2023-2032)
... 2023 to 2032. The aging global population is increasing the prevalence of chronic diseases, creating high demand for regenerative therapies. The rising advancements in stem cell research, gene therapy, and tissue engineering are also expanding ... Read More
-
Gene Therapy
... therapy for more than 200 rare disease indications, and in the EU, over 70 products for about 45 indications. Furthermore, in the field of molecular and cellular biology, rapid and important developments, led by technological ... Read More
Research Assistance
